Cargando…
MEF/ELF4 transactivation by E2F1 is inhibited by p53
Myeloid elf-1-like factor (MEF) or Elf4 is an E-twenty-six (ETS)-related transcription factor with strong transcriptional activity that influences cellular senescence by affecting tumor suppressor p53. MEF downregulates p53 expression and inhibits p53-mediated cellular senescence by transcriptionall...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017608/ https://www.ncbi.nlm.nih.gov/pubmed/20805247 http://dx.doi.org/10.1093/nar/gkq762 |
_version_ | 1782195925695856640 |
---|---|
author | Taura, Manabu Suico, Mary Ann Fukuda, Ryosuke Koga, Tomoaki Shuto, Tsuyoshi Sato, Takashi Morino-Koga, Saori Okada, Seiji Kai, Hirofumi |
author_facet | Taura, Manabu Suico, Mary Ann Fukuda, Ryosuke Koga, Tomoaki Shuto, Tsuyoshi Sato, Takashi Morino-Koga, Saori Okada, Seiji Kai, Hirofumi |
author_sort | Taura, Manabu |
collection | PubMed |
description | Myeloid elf-1-like factor (MEF) or Elf4 is an E-twenty-six (ETS)-related transcription factor with strong transcriptional activity that influences cellular senescence by affecting tumor suppressor p53. MEF downregulates p53 expression and inhibits p53-mediated cellular senescence by transcriptionally activating MDM2. However, whether p53 reciprocally opposes MEF remains unex-plored. Here, we show that MEF is modulated by p53 in human cells and mice tissues. MEF expression and promoter activity were suppressed by p53. While we found that MEF promoter does not contain p53 response elements, intriguingly, it contains E2F consensus sites. Subsequently, we determined that E2F1 specifically binds to MEF promoter and transactivates MEF. Nevertheless, E2F1 DNA binding and transactivation of MEF promoter was inhibited by p53 through the association between p53 and E2F1. Furthermore, we showed that activation of p53 in doxorubicin-induced senescent cells increased E2F1 and p53 interaction, diminished E2F1 recruitment to MEF promoter and reduced MEF expression. These observations suggest that p53 downregulates MEF by associating with and inhibiting the binding activity of E2F1, a novel transcriptional activator of MEF. Together with previous findings, our present results indicate that a negative regulatory mechanism exists between p53 and MEF. |
format | Text |
id | pubmed-3017608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-30176082011-01-10 MEF/ELF4 transactivation by E2F1 is inhibited by p53 Taura, Manabu Suico, Mary Ann Fukuda, Ryosuke Koga, Tomoaki Shuto, Tsuyoshi Sato, Takashi Morino-Koga, Saori Okada, Seiji Kai, Hirofumi Nucleic Acids Res Gene Regulation, Chromatin and Epigenetics Myeloid elf-1-like factor (MEF) or Elf4 is an E-twenty-six (ETS)-related transcription factor with strong transcriptional activity that influences cellular senescence by affecting tumor suppressor p53. MEF downregulates p53 expression and inhibits p53-mediated cellular senescence by transcriptionally activating MDM2. However, whether p53 reciprocally opposes MEF remains unex-plored. Here, we show that MEF is modulated by p53 in human cells and mice tissues. MEF expression and promoter activity were suppressed by p53. While we found that MEF promoter does not contain p53 response elements, intriguingly, it contains E2F consensus sites. Subsequently, we determined that E2F1 specifically binds to MEF promoter and transactivates MEF. Nevertheless, E2F1 DNA binding and transactivation of MEF promoter was inhibited by p53 through the association between p53 and E2F1. Furthermore, we showed that activation of p53 in doxorubicin-induced senescent cells increased E2F1 and p53 interaction, diminished E2F1 recruitment to MEF promoter and reduced MEF expression. These observations suggest that p53 downregulates MEF by associating with and inhibiting the binding activity of E2F1, a novel transcriptional activator of MEF. Together with previous findings, our present results indicate that a negative regulatory mechanism exists between p53 and MEF. Oxford University Press 2011-01 2010-08-30 /pmc/articles/PMC3017608/ /pubmed/20805247 http://dx.doi.org/10.1093/nar/gkq762 Text en © The Author(s) 2010. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/2.5 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Gene Regulation, Chromatin and Epigenetics Taura, Manabu Suico, Mary Ann Fukuda, Ryosuke Koga, Tomoaki Shuto, Tsuyoshi Sato, Takashi Morino-Koga, Saori Okada, Seiji Kai, Hirofumi MEF/ELF4 transactivation by E2F1 is inhibited by p53 |
title | MEF/ELF4 transactivation by E2F1 is inhibited by p53 |
title_full | MEF/ELF4 transactivation by E2F1 is inhibited by p53 |
title_fullStr | MEF/ELF4 transactivation by E2F1 is inhibited by p53 |
title_full_unstemmed | MEF/ELF4 transactivation by E2F1 is inhibited by p53 |
title_short | MEF/ELF4 transactivation by E2F1 is inhibited by p53 |
title_sort | mef/elf4 transactivation by e2f1 is inhibited by p53 |
topic | Gene Regulation, Chromatin and Epigenetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017608/ https://www.ncbi.nlm.nih.gov/pubmed/20805247 http://dx.doi.org/10.1093/nar/gkq762 |
work_keys_str_mv | AT tauramanabu mefelf4transactivationbye2f1isinhibitedbyp53 AT suicomaryann mefelf4transactivationbye2f1isinhibitedbyp53 AT fukudaryosuke mefelf4transactivationbye2f1isinhibitedbyp53 AT kogatomoaki mefelf4transactivationbye2f1isinhibitedbyp53 AT shutotsuyoshi mefelf4transactivationbye2f1isinhibitedbyp53 AT satotakashi mefelf4transactivationbye2f1isinhibitedbyp53 AT morinokogasaori mefelf4transactivationbye2f1isinhibitedbyp53 AT okadaseiji mefelf4transactivationbye2f1isinhibitedbyp53 AT kaihirofumi mefelf4transactivationbye2f1isinhibitedbyp53 |